JPH02154638A - Production of fermented milk with lactobacillus bifidus - Google Patents
Production of fermented milk with lactobacillus bifidusInfo
- Publication number
- JPH02154638A JPH02154638A JP30515288A JP30515288A JPH02154638A JP H02154638 A JPH02154638 A JP H02154638A JP 30515288 A JP30515288 A JP 30515288A JP 30515288 A JP30515288 A JP 30515288A JP H02154638 A JPH02154638 A JP H02154638A
- Authority
- JP
- Japan
- Prior art keywords
- fermented milk
- container
- bifidobacteria
- milk
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 235000015140 cultured milk Nutrition 0.000 title abstract description 13
- 229940068140 lactobacillus bifidus Drugs 0.000 title abstract 4
- 230000004888 barrier function Effects 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 12
- 239000008267 milk Substances 0.000 claims abstract description 12
- 210000004080 milk Anatomy 0.000 claims abstract description 12
- 239000000796 flavoring agent Substances 0.000 abstract description 14
- 235000019634 flavors Nutrition 0.000 abstract description 14
- 230000004083 survival effect Effects 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 5
- 241000194017 Streptococcus Species 0.000 abstract description 3
- 238000011049 filling Methods 0.000 abstract description 3
- 239000011521 glass Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 239000003566 sealing material Substances 0.000 abstract 1
- 241000186000 Bifidobacterium Species 0.000 description 35
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 26
- 238000000855 fermentation Methods 0.000 description 22
- 230000004151 fermentation Effects 0.000 description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 13
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 13
- 239000007858 starting material Substances 0.000 description 13
- 239000007789 gas Substances 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 235000019645 odor Nutrition 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013861 fat-free Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000020185 raw untreated milk Nutrition 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- -1 EVAL Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 101000619903 Mycolicibacterium smegmatis L-lactate 2-monooxygenase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Dairy Products (AREA)
Abstract
Description
【発明の詳細な説明】
ア)産業上の利用分野
本発明は、ヒフィズス菌醗酵乳の製造法に係わるもので
ある。ビフィズス菌は人の腸内に常在する微生物である
が、その腸内での消長が人の健康と深い係わりを持つこ
とが知られており、人の腸内菌叢をビフィズス菌優位の
菌叢に改善することが各種病気の予防、治療に役立つも
のと考えられ、様々なビフィズス菌を含んだ製品の市場
が形成されている。ビフィズス菌の予防、治療効果とし
て腸内有害菌の排除、免疫賦活、感染防御、発癌の抑制
、その他整腸作用等が報告されている。DETAILED DESCRIPTION OF THE INVENTION A) Industrial Application Field The present invention relates to a method for producing Hifidobacterium fermented milk. Bifidobacterium is a microorganism that always resides in the human intestine, and it is known that its status in the intestine is closely related to human health. It is believed that improving the bifidobacterium flora is useful for preventing and treating various diseases, and a market has been formed for products containing various bifidobacteria. The preventive and therapeutic effects of bifidobacteria have been reported to include elimination of harmful intestinal bacteria, immune activation, infection prevention, suppression of carcinogenesis, and other intestinal regulation effects.
製造する際にガスバリヤ−性の高い容器を使用し、かつ
ヘッドスペースの無い状態で充填密封することにより、
風味が良く、ビフィズス菌の生残性が良いことに特徴を
有するより優れたビフィズス菌醗酵乳を、工業的に有利
に収得することを目的とする。By using containers with high gas barrier properties during manufacturing and filling and sealing without head space,
The purpose of the present invention is to industrially advantageously obtain superior bifidobacterium-fermented milk, which is characterized by good flavor and good survival of bifidobacteria.
イ)従来の技術及びその問題点
一般にビフィズス菌は、以下のような性質を有している
ため、醗酵乳中での生菌数の急激な減少が認められる。B) Conventional techniques and their problems In general, bifidobacteria have the following properties, and therefore a rapid decrease in the number of viable bacteria in fermented milk is observed.
その理由として、偏性嫌気性菌であるため、酸素の存在
下で死滅しやすいこと。ビフィズス菌は通常の乳業用乳
酸菌に比較して著しく耐酸性が弱く、醗酵乳中で生産さ
れた乳酸のために急速に死滅すること等があげられる。The reason for this is that it is an obligate anaerobic bacterium, so it easily dies in the presence of oxygen. Bifidobacteria have significantly weaker acid resistance than normal dairy lactic acid bacteria, and are rapidly killed by lactic acid produced in fermented milk.
この様な醗酵乳中でのビフィズス菌数の減少を、防止す
るため、−船釣には次のような処理方法が採用されてい
る。■ビフィズス菌に、耐酸性や酸素に対する抵抗性付
与した変異株を取得し、これを使用してビフィズス菌醗
酵乳を製造する方法。■酵母あるいは枯草菌等のカタラ
ーゼを産生する微生物、あるいはその無細胞抽出液を添
加し、系内で産生されるH、O□を除去する方法。■酸
素吸収能の高いストレフトコッカス、サーモフィラスを
使用する方法。あるいは■L−アスコルビン酸とラクト
バチラス、アシドフィラスを添加させる等、保存系内の
溶存酸素を減少させる方法。■ストレフトコッカス、ダ
イアセチラクティスを共存させる。あるいは■乳酸モノ
オキシゲナーゼを使用する。など系内で炭酸ガスを産生
する。等々の方法が採用されている。In order to prevent such a decrease in the number of bifidobacteria in fermented milk, the following treatment method is adopted for boat fishing. ■A method of obtaining a mutant strain of Bifidobacterium that has resistance to acid and oxygen, and using this to produce Bifidobacterium-fermented milk. ■A method in which a microorganism that produces catalase, such as yeast or Bacillus subtilis, or a cell-free extract thereof is added to remove H and O□ produced within the system. ■Method using Streftococcus and Thermophilus, which have high oxygen absorption capacity. Alternatively, (2) A method of reducing dissolved oxygen in the preservation system, such as adding L-ascorbic acid and Lactobacillus or Acidophilus. ■Streptococcus and Diacetylactis coexist. Alternatively, ■ use lactate monooxygenase. etc. Produces carbon dioxide gas within the system. Other methods have been adopted.
しかしながら、ビフィズス菌の変異株の使用は、自然な
状態のビフィズス菌ではないという問題を含んでいるこ
と、還元剤を醗酵孔に添加することは添加物を使用する
ことになり、ブレーンタイプのビフィズス菌醗酵乳に不
適である。一方、酵母の添加においては、産生される炭
酸ガスのため容器に耐圧性の付与が必要であり、また産
生ガス量の制御は極めて難しい。さらに、ストレプトコ
ンカス、ダイアセチラクチティスを共存させた場合、過
剰に産生されるダイアセチル及びアセトインは、風味上
好ましいものとは言えない。However, the use of mutant strains of Bifidobacterium involves the problem that they are not Bifidobacteria in their natural state, and adding a reducing agent to the fermentation pores requires the use of additives. Not suitable for bacterially fermented milk. On the other hand, when adding yeast, it is necessary to provide pressure resistance to the container because of the carbon dioxide gas produced, and it is extremely difficult to control the amount of produced gas. Furthermore, when Streptoconcus and diacetylactitis coexist, excessively produced diacetyl and acetoin are not favorable in terms of flavor.
つ)問題点を解決するための手段
発明者は、以上のような問題点を解決すべく研究を重ね
たX1〜果、本発明を完成するに至った。すなわち、ス
トレブi・コツカス ダイアセチラクティスと、ヒ゛フ
ィズス菌とを共存させた醗酵孔を製造するに際し、ガス
バリヤ−性の高い容器を使用し、かつ、ヘッドスペース
の無い状態で充填密封とすることにより、ビフィズス菌
の醗酵乳中での生残性を良好に保ちつつ、かつダイアセ
チル及びアセトインの風味の発生が僅少に抑制され、良
好な風味の醗酵孔が得られることを発見した。(1) Means for Solving the Problems The inventor has conducted extensive research to solve the above-mentioned problems, and as a result, he has completed the present invention. That is, when producing a fermentation hole in which Streb I. coccus diacetylactis and Hyphidobacterium coexist, a container with high gas barrier properties is used and the container is filled and sealed without head space. It has been discovered that while the survival of bifidobacteria in fermented milk is maintained well, the generation of diacetyl and acetoin flavors is slightly suppressed, and fermentation holes with good flavor can be obtained.
ビフィズス菌は、醗酵乳中では急激な死滅傾向を示すが
、本出願人の特開昭63−94938において開示し!
ことおり、ストレプトコンカス、ダイアセチラフティス
スと共存させた場合には、製品保存中の生残性が著しく
改善される。ストレフトコッカス、ダイアセチラクティ
スは、乳を主原料とする醗酵基質中のクエン酸から脱炭
酸反応を行い、ダイアセチル及びアセトインを生成する
。Bifidobacterium shows a rapid tendency to die in fermented milk, but this was disclosed in Japanese Patent Application Laid-Open No. 63-94938 by the present applicant.
When used together with Streptoconcus and Diacetylarftis, the survivability of the product during storage is significantly improved. Streftococcus and diacetylactis perform a decarboxylation reaction from citric acid in a fermentation substrate made mainly of milk to produce diacetyl and acetoin.
この脱炭酸反応によって生じた二酸化炭素が、醗酵乳中
の嫌気度を増加させ、ビフィズス菌の保存に効果を発渾
していることが知得されている。嫌気性菌は、高い酸化
還元′に位によって生育が停止し、酸素による酸化反応
・生成される過酸化水素によって、死滅すると考えられ
ており、従って、系内即ち製品容器内から酸素を追い出
すことによって、ビフィズス菌の生残性は改善されるの
である。It is known that carbon dioxide generated by this decarboxylation reaction increases the anaerobic degree in fermented milk and is effective in preserving bifidobacteria. It is believed that the growth of anaerobic bacteria stops due to high levels of redox and is killed by the oxidation reaction with oxygen and the hydrogen peroxide produced. This improves the survival of bifidobacteria.
しかしながら、ビフィズス菌の生残性改善にストレフト
コッカス、ダイアセチラクティスを用いる場合、炭酸ガ
スと同時にダイアセチル及びアセトインが産生される。However, when Streftococcus and Diacetylactis are used to improve the survival of Bifidobacteria, diacetyl and acetoin are produced simultaneously with carbon dioxide gas.
ダイアセチル及びアセトインは、ヨーグルト、醗酵クリ
ームや醗酵バター等の重要な呈味成分ではあるが、これ
が過剰に生産された場合は、ある種の生臭さが感じられ
、必ずしも好ましい風味とはならない。そこで、発明者
は、アセトインからダイアセチルへの変換が、好気条件
下で起こることに着目して、ビフィズス苗醗酵乳を製造
するに際し、ガスバリヤ−性の高い容器を使用し、ヘッ
ドスペースの無い状態で密封することを試みた。その結
果、ストレフトコッカス、ダイアセチラクテイスによっ
て生起される生臭さは大幅に減少し、呈味成分のバラン
スのとれた好ましい風味となることを発見した。そして
同時に保存期間中のビフィズス菌の生残性は、良好な状
態に保たれていた。これらの知見に基づき、本発明を完
成するに至った。以下に本発明の詳細な説明する。Diacetyl and acetoin are important flavor components of yogurt, fermented cream, fermented butter, etc., but when they are produced in excess, a certain fishy odor is felt and the flavor is not necessarily desirable. Therefore, the inventor focused on the fact that the conversion of acetoin to diacetyl occurs under aerobic conditions, and when producing bifidus seedling fermented milk, he used a container with high gas barrier properties and a container with no head space. I tried to keep it sealed. As a result, it was discovered that the fishy odor caused by Streftococcus and Diacetylactis was significantly reduced, resulting in a pleasant flavor with well-balanced taste components. At the same time, the survivability of bifidobacteria was maintained in good condition during the storage period. Based on these findings, we have completed the present invention. The present invention will be explained in detail below.
工)作用
本発明の醗酵孔の製造工程は、生乳・乳性原料を主原料
とし、要すれば、しょ糖・果汁等を添加し、常法通り均
質化・殺菌処理をしたものを醗酵基質とする。ビフィズ
ス菌スターター、ストレフトコッカス、ダイアセチラフ
ティススターター、更に要すれば従来の乳業用乳酸菌ス
ターターをそれぞれ、1.0%〜10.0%(v/v)
を基質に添加する。容器はガスバリヤ−性の高い材質例
えばガラス、PET、EVAL、PVDCなど用いたも
のが採用される。この容器にへ/トスペースが無い状態
となるように充填し、同じくガスバリヤ−性の高い材質
を用いたンール材で密封する。このものを20〜40°
C1好ましくは、30〜35℃の温度域にて、乳酸酸度
が0.70〜1.00%(v/w)となるまで醗酵した
のち、これを冷却する。ビフィズス菌と、ストレフトコ
ッカス、ダイアセチラクティスとは、必ずしも同時に使
用して醗酵しなくても良く、個別に醗酵したビフィズス
菌スターターと、ストレフトコッカス、ダイアセチラフ
ティススターターを、従来の乳業用乳酸菌で醗酵した醗
酵孔に事後添加しても、ビフィズス菌の生残性は良好に
保たれる。The process for manufacturing the fermentation hole of the present invention uses raw milk/milk raw materials as the main raw materials, and if necessary, adds sucrose, fruit juice, etc., and homogenizes and sterilizes them in the usual manner as the fermentation substrate. do. 1.0% to 10.0% (v/v) of Bifidobacterium starter, Streftococcus, Diacetylarftis starter, and if necessary, conventional lactic acid bacteria starter for dairy industry.
is added to the substrate. The container is made of a material with high gas barrier properties, such as glass, PET, EVAL, or PVDC. This container is filled so that there is no waste space, and is sealed with a seal material also made of a material with high gas barrier properties. This thing 20~40°
C1 Preferably, fermentation is performed at a temperature range of 30 to 35°C until the lactic acid acidity becomes 0.70 to 1.00% (v/w), and then cooled. Bifidobacterium, Streftococcus, and Diacetylactis do not necessarily have to be used together for fermentation, and Bifidobacterium starter, Streftococcus, and Diacetylactis starter that have been fermented separately can be used in the conventional dairy industry. Even if it is added afterward to the fermentation hole where fermentation was carried out with lactic acid bacteria, the survival of bifidobacteria is maintained well.
この際ストレプトコンカス、ダイアセチラクティスは、
酸素ど遮断して培養しなけれはならない。充填前の醗酵
孔は溶存酸素量をなるへく低く保つため、殺菌時に脱気
工程を通す等により、ビフィズス菌の生残性を一層良く
することが出来る。At this time, Streptoconcus and Diacetylactis are
It must be cultured with oxygen cut off. In order to keep the amount of dissolved oxygen in the fermentation pores as low as possible before filling, the survivability of bifidobacteria can be further improved by passing through a degassing process during sterilization.
以上が、本発明の目的とするビフィズス菌の生残性が良
く、かつ風味の良好なビフィズス菌醸酵乳の製造法であ
る。尚、以下実施例に基づき本発明の作用効果を説明す
る。The above is the method for producing bifidobacteria-fermented milk, which is the object of the present invention and has good survival of bifidobacteria and a good flavor. Hereinafter, the effects of the present invention will be explained based on Examples.
才)実施例−1
本例では、バリヤー性の高い容器としてガラス容器を用
い、蓋材としてアルミシールを付し、ヘッドスペースの
無い状態のもの及び、醗酵孔80m1に対し20m1の
へ。Example 1 In this example, a glass container with high barrier properties was used, an aluminum seal was attached as a lid material, there was no head space, and the fermentation hole was 20 m1 in size compared to 80 m1.
トスペースを持った状態をそれぞれ用意し、両者の比較
を行った。尚、醗酵孔は以下の方法にて調整した。即ち
、無脂乳固形分が10%(v/w)になるように脱脂粉
乳により強化した生乳を常法通り均質化し、95°Cに
て30分間加熱処理した後33°Cに冷却したものを醗
酵基質とした。使用するスターターは無脂乳固形分lO
%(v/v)の脱脂粉乳還元乳を、95℃にて30分間
加熱殺菌したものを共通培地とした。乳酸醗酵を進め、
良好な醗酵孔の風味を生成する、l−ターとして、スト
レフトコッカス、サーモフィラスとラクトバチラス、ブ
ルガリカスとを1.9 : 0.1の比で接種し、36
℃にて17時間培養し、乳酸菌スターターを調整した。We prepared a state with each space and compared the two. In addition, the fermentation hole was adjusted by the following method. That is, raw milk fortified with skim milk powder so that the non-fat milk solids content is 10% (v/w) is homogenized in a conventional manner, heat-treated at 95°C for 30 minutes, and then cooled to 33°C. was used as the fermentation substrate. The starter used is 1O non-fat milk solids.
% (v/v) of skim milk powder was heat sterilized at 95° C. for 30 minutes and used as a common medium. Proceed with lactic acid fermentation,
Streftococcus thermophilus and Lactobacillus bulgaricus were inoculated at a ratio of 1.9:0.1 to produce a good fermentation flavor.
The lactic acid bacteria starter was prepared by culturing at ℃ for 17 hours.
一方、ビフィズス菌スターターはビフィドバクテリウム
、ロンガムを接種し、34℃にて嫌気条件下で17時間
培養し調整した。ストレフトコッカス、ダイアセチラフ
ティススターターは、ビフィドバクテリウム、ロンガム
とストレフトコッカス、ダイアセチラクティスとを5:
2の比で接種し、34°Cにて17時間培養し調整した
。On the other hand, Bifidobacterium starter was prepared by inoculating Bifidobacterium and longum and culturing it under anaerobic conditions at 34°C for 17 hours. Streftococcus, diacetylactis starter contains Bifidobacterium longum and Streftococcus, diacetylactis 5:
The cells were inoculated at a ratio of 2:2 and cultured at 34°C for 17 hours for adjustment.
醗酵基質に乳酸菌スターターを3.0%(V/V)、ビ
フィズス菌スターターを5.0%(V/す、ストレズト
コッヵス、ダイアセチラクティススターター1.0%C
v/りを、それぞれ添加し、撹はん均−後夫々前述の容
器に前述の状態で充填し33°Cで醗酵した。醗酵後の
両者の風味の経日的変化を専門パネル20人で評価した
。その結果は表−1の通りである。Fermentation substrates include 3.0% (V/V) lactic acid bacteria starter, 5.0% (V/S) Bifidobacterium starter, 1.0% C Streztococcus, and Diacetylactis starter.
After adding v/li to each, stirring and homogenizing, the above-mentioned containers were respectively filled in the above-mentioned state and fermented at 33°C. A panel of 20 experts evaluated the changes in flavor of both products over time after fermentation. The results are shown in Table-1.
(注)ダイアセチル、アセトモノ臭の評gBニー±
+
++
+++
はとんど感じない
やや感じる
感じる
強く感じる
非業に強く怒じる
風味の評(i[Ii(専門パネル20名)美味しい
やや美味しい
普通
ややまずい
まずい
実施例−1で、示すごとくガスバリヤ−性のあるセチル
及びアセトイン臭は発生せず、良好な風味がれ/こ。(Note) Diacetyl and acetomono odor reviews gB + + + + + + + + + ++ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + ++ In Example 1, which is normally a little tasteless and tasteless, as shown, cetyl and acetoin, which have gas barrier properties, did not generate odor and had a good flavor.
実施例−2
無脂乳固形分が9 、 Sjf(w/w)になるように
脱脂粉乳り強化した生乳を常法通り均質化し、95°C
にて30分−ターを3.0%(V/す、ビフィズス菌ス
ターターを5゜容器に充填し、ヘッドスペースの無い状
態でアルミ10°Cで保存したときのビフィズス菌数(
個/ml)及表−2である。Example-2 Raw milk enriched with skim milk powder so that the non-fat milk solids content was 9.Sjf (w/w) was homogenized in a conventional manner and heated to 95°C.
The number of Bifidobacteria when the Bifidobacterium starter was filled in a 5° container and stored in aluminum at 10°C without head space.
number/ml) and Table 2.
(注)■乳酸酸度(滴定法)
■ビフィズス菌数(BL血液平板を使用した嫌気培養法
)
■ストレフトコッカス
以下の組成の培地を使用して選択計数した。(Note) ■Lactic acid acidity (titration method) ■Bifidobacteria count (anaerobic culture method using BL blood plate) ■Streptococcus Selective counting was performed using a medium with the following composition.
組成
ホエー 1000 mトリプ
チケースペプトン
グルコース 5.0g寒天
15.0gPl−I
6.6
A液及びB液それぞれ1%(v/v)をオートクレー7
滅菌した上記培地に添加後使用する。Composition Whey 1000 m Trypticase Peptone Glucose 5.0 g Agar
15.0gPl-I
6.6 Add 1% (v/v) of each of liquid A and liquid B to autoclay 7.
Use after adding to the above sterilized medium.
A液:10 % フェリシアン化カリウムB液:2.
5% クエン酸第二鉄
2、5% クエン酸ナトリウム
A液、B液それぞれフィルター滅菌して使用する。Solution A: 10% Potassium ferricyanide Solution B: 2.
5% ferric citrate 2, 5% sodium citrate Solutions A and B are each sterilized by filter before use.
参考文献
G. M. Kempler and L. L. M
ckeyJ 、 Dairy Sci. 、 64.
1527−ls39, 1981■乳酸菌数(BCP培
地による常法)
実施例−2に示すごとく、ビフィズス菌とストレフトコ
ッカス、ダイアセチラクティスとを共存させた場合では
、ヘントスペースの全く無い充填状態にしても、醗酵孔
80mlに対し、2 0 m lのヘッドスペースを持
った状態とほぼ等しいビフィズス菌の生残性が得られた
。また風味的には、ダイアセチル及びアセトイン臭の少
ない美味なものとなった。ReferencesG. M. Kempler and L. L. M
ckeyJ, Dairy Sci. , 64.
1527-ls39, 1981 ■ Lactic acid bacteria count (conventional method using BCP medium) As shown in Example 2, when Bifidobacterium, Streftococcus, and Diacetylactis coexist, it is packed in a state with no hent spaces. In this case, the survival of bifidobacteria was almost the same as when the fermentation hole had a head space of 20 ml with respect to 80 ml. In terms of flavor, it was delicious with little diacetyl and acetoin odor.
ツノ)発明の効果
ビフィズス菌の醗酵乳中での生残性を改善するため、ス
トレフトコッカス。ダイアセチラクティスと共存させ、
系内に炭酸ガスを生成させ、嫌気度を高めビフィズス菌
の保護を行うとき、この際同時に生成するダイアセチル
及びアセトインが風味を損していた。本発明は、アセト
インからダイアセチルへの変換が、好気条件下で進行す
ることに着目し、当該醗酵孔を空気即ち酸素から遮断す
ることを試み、ガスバリヤ−性の高い容器、器材を用い
、ヘッドスペースの無い状態において充填密封し、醗酵
させた。これにより、ダイアセチル及びアセトイン臭が
生成せずかつ、ビフィズス菌の生残性の良好な醗酵孔を
収得するのに成功した。ヘッドスペースの無い嫌気状態
で醗酵することにより、アセトインからダイアセチルへ
の変換が抑制された結果と推測されるが、詳細は解らな
い。Effects of the invention In order to improve the survival of Bifidobacterium in fermented milk, Streftococcus. coexist with diacetylactis,
When carbon dioxide gas is generated in the system to increase the anaerobic degree and protect bifidobacteria, diacetyl and acetoin, which are simultaneously generated, impair flavor. The present invention focuses on the fact that the conversion of acetoin to diacetyl proceeds under aerobic conditions, attempts to block the fermentation pores from air, that is, oxygen, and uses containers and equipment with high gas barrier properties. The mixture was filled and sealed in the absence of head space and fermented. As a result, it was possible to successfully obtain fermentation pores in which diacetyl and acetoin odors were not produced and Bifidobacterium had good survival. It is assumed that this is due to the fact that the conversion of acetoin to diacetyl is suppressed by fermentation under anaerobic conditions without headspace, but the details are not known.
現象としては、ダイアセチル及びアセトイン臭の持つ生
臭さのないものであり、ビフィズス菌の生残性も高く、
予防治療効果の期待される、極めて商業的にも価値のあ
る発明であった。The phenomenon is that there is no fishy odor associated with diacetyl and acetoin odor, and the survival of bifidobacteria is high.
It was an extremely commercially valuable invention that was expected to have preventive and therapeutic effects.
(以上)(that's all)
Claims (1)
ビフィズス菌醗酵乳をガスバリヤー性の高い容器に充填
し、かつヘッドスペースの無い状態で密封することを特
徴とする、風味が良くビフィズス菌の生残性の良いビフ
ィズス菌醗酵乳の製造法。Bifidobacterium-fermented milk containing Streftococcus and Diacetylactis is filled into a container with high gas barrier properties and sealed without head space. A method for producing good bifidobacteria-fermented milk.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30515288A JPH02154638A (en) | 1988-12-03 | 1988-12-03 | Production of fermented milk with lactobacillus bifidus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30515288A JPH02154638A (en) | 1988-12-03 | 1988-12-03 | Production of fermented milk with lactobacillus bifidus |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02154638A true JPH02154638A (en) | 1990-06-14 |
JPH0355089B2 JPH0355089B2 (en) | 1991-08-22 |
Family
ID=17941699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30515288A Granted JPH02154638A (en) | 1988-12-03 | 1988-12-03 | Production of fermented milk with lactobacillus bifidus |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02154638A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006042661A (en) * | 2004-08-03 | 2006-02-16 | Kirin Brewery Co Ltd | Fermented malt beverage with lactobacillus or fermented beverage with malt substitute and method for producing the same |
JP2006050979A (en) * | 2004-08-12 | 2006-02-23 | Kirin Brewery Co Ltd | Lactobacillus-containing fermented malt beverage or malt substitute beverage having anti-allergic function, and method for producing the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51144745A (en) * | 1975-06-09 | 1976-12-13 | Takenori Nakagaki | Method of producing food having good preservability |
JPS6394938A (en) * | 1986-10-08 | 1988-04-26 | Glyco Kyodo Nyugyo Kk | Production of fermented milk of lactobacillus bifidus |
-
1988
- 1988-12-03 JP JP30515288A patent/JPH02154638A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51144745A (en) * | 1975-06-09 | 1976-12-13 | Takenori Nakagaki | Method of producing food having good preservability |
JPS6394938A (en) * | 1986-10-08 | 1988-04-26 | Glyco Kyodo Nyugyo Kk | Production of fermented milk of lactobacillus bifidus |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006042661A (en) * | 2004-08-03 | 2006-02-16 | Kirin Brewery Co Ltd | Fermented malt beverage with lactobacillus or fermented beverage with malt substitute and method for producing the same |
JP2006050979A (en) * | 2004-08-12 | 2006-02-23 | Kirin Brewery Co Ltd | Lactobacillus-containing fermented malt beverage or malt substitute beverage having anti-allergic function, and method for producing the same |
JP4587368B2 (en) * | 2004-08-12 | 2010-11-24 | 麒麟麦酒株式会社 | Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
JPH0355089B2 (en) | 1991-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6599543B1 (en) | Process for preparing fermented soybean milk | |
JP2975148B2 (en) | Fermented milk and method for producing the same | |
US4187321A (en) | Method for producing foods and drinks containing bifidobacteria | |
CA2030630A1 (en) | Method of preparing milk-fermented food | |
JP3068484B2 (en) | Bifidobacterium fermented milk and method for producing the same | |
JPH0153035B2 (en) | ||
JPH0584065A (en) | New lactobacillus and fermented ginseng juice prepared by using the same | |
JP2001112437A (en) | Production of food and drink containing bacteria of genus bifidobacterium | |
JPH02154638A (en) | Production of fermented milk with lactobacillus bifidus | |
JPH029781B2 (en) | ||
US5236833A (en) | Diacetyl production | |
JPS5951997B2 (en) | A novel microorganism belonging to Streptococcus thermophilus and a composition containing the microorganism | |
JPS63251070A (en) | Fruit juice food prepared by lactic acid fermentation | |
JPH1175688A (en) | Vessel-contained soybean milk undergoing lactic fermentation | |
WO2010113816A1 (en) | Method for culturing lactic acid bacterium and method for producing fermented milk | |
JPH0795915B2 (en) | Method for producing non-heated meat products with excellent shelf life | |
JP2001321072A (en) | New method for producing fermented milk containing bacillus bifidus | |
JP2843963B2 (en) | Method for improving survival of bifidobacteria | |
JPS6053580B2 (en) | Method for producing bifidobacteria-fermented milk | |
RU2548813C1 (en) | Whey beverage production method (versions) | |
Fessler | Characterization of Propionibacteria in Swiss raw milk by biochemical and molecular-biological methods | |
JPH1132724A (en) | Production of food or drink high in survival rate of bacillus bifidus | |
JPH01257476A (en) | Bifidobacterium-breve and food and drink | |
JP3007686B2 (en) | Lactic acid bacterium starter containing peroxidase, fermented milk product, and methods for producing the same | |
JP3156019B2 (en) | Fermented milk and its production method |